| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Change in fair value of convertible note | - | - | 58 | - |
| Income (loss) before taxes on income | 545 | -3,909 | -2,480 | -995 |
| Income tax expenses | 35 | 62 | 15 | 3 |
| Net income (loss) | 510 | -3,971 | -2,495 | -998 |
| Deemed contribution | - | -3,815 | - | - |
| 8 dividend on convertible preferred series x | 758 | 344 | - | - |
| 9 dividend on convertible preferred series h | 223 | - | - | - |
| Deemed dividend for down round on series h | 399 | - | - | - |
| Deemed contribution on repurchase of preferred series x | -90 | - | - | - |
| Net loss available to common stockholders | -780 | -500 | - | - |
| Basic net loss available for holders of common stock | -0.91 | -1.03 | - | -0.36 |
| Diluted net loss available for holders of common stock | -0.91 | -1.03 | 3.98 | -0.36 |
| Weighted average common stock outstanding, basic | 858,434 | 484,566 | 626,150 | 2,803,181 |
| Weighted average common stock outstanding, diluted | 858,434 | 484,566 | 626,150 | 2,803,181 |
NanoVibronix, Inc. (NAOV)
NanoVibronix, Inc. (NAOV)